Left Ventricular Apical Aneurysm in Fabry Disease: Implications for Clinical Significance and Risk Stratification

Hao Chih Chang, Ling Kuo, Shih Hsien Sung, Ching Yao Weng, Chun Ku Chen, Dau Ming Niu, Shih Ann Chen, Wen Chung Yu*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


BACKGROUND: A previously underrecognized phenotype of left ventricular apical aneurysm (LVAA) has been increasingly identified in Fabry disease. This study explored LVAA’s clinical prevalence and its prognostic implications over a long-term follow-up. METHODS AND RESULTS: We retrospectively analyzed 268 consecutive patients with Fabry disease at a tertiary medical center. Patients with increased left ventricular mass index were recognized as having left ventricular hypertrophy (LVH). LVAA was identified using either echocardiography or cardiovascular magnetic resonance imaging. Two patients with ischemic LVAA were excluded. The primary end point was a composite of cardiovascular events, including heart failure hospitalization, sustained ventricular tachycardia, ischemic stroke, and all-cause mortality. Of 266 enrolled patients, 105 (39.5%) had LVH (age 58.5±11.9 years, 48.6% men), and 11 (10.5%) had LVAA. Over 49.3±34.8 months of follow-up, 25 patients with LVH experienced composite events, including 9 heart failure hospitalizations, 4 sustained ventricular tachycardia, 6 ischemic strokes, and 15 mortalities. In patients with LVH, those with LVAA had a significantly higher risk of composite events and lower event-free survival than those without LVAA (8 [72.7%] versus 17 [18.1%], log-rank P<0.001). LVAA was independently associated with an increased risk of composite events (hazard ratio, 3.59 [95% CI, 1.30–9.91]; P=0.01) after adjusting for age, sex, advanced heart failure, renal function, dyslipidemia, atrial fibrillation, left ventricular ejection fraction, left ventricular diastolic function, and left ventricular mass index. CONCLUSIONS: LVAA is present in approximately 10% of patients with Fabry disease and LVH. It is associated with an increased risk of adverse cardiovascular events and may necessitate aggressive treatment.

Original languageEnglish
Article numbere027041
JournalJournal of the American Heart Association
Issue number1
StatePublished - 16 Aug 2023


  • cardiovascular magnetic resonance
  • echocardiography
  • Fabry disease
  • left ventricular apical aneurysm
  • left ventricular hypertrophy


Dive into the research topics of 'Left Ventricular Apical Aneurysm in Fabry Disease: Implications for Clinical Significance and Risk Stratification'. Together they form a unique fingerprint.

Cite this